Farncombe Institute

September 28, 2010 06:00 ET

Farncombe Institute Recruits Top Microbiologist to Probe the Causes of Inflammatory Bowel Disease

HAMILTON, ONTARIO--(Marketwire - Sept. 28, 2010) - McMaster University's Farncombe Family Institute for Digestive Health Research has recruited Dr. Michael Surette to lead an initiative to better understand the contribution of intestinal bacteria to inflammatory bowel diseases (Crohn's disease and ulcerative colitis). Dr. Surette is an internationally recognized expert in microbiology, having made landmark discoveries of key bacteria responsible for triggering infection of the lung in cystic fibrosis. 

John Wallace, Professor of Medicine and Director of the Farncombe Institute, described Surette's discoveries as "remarkable and life-changing". "Mike Surette has been able to significantly improve the lives of individuals afflicted with cystic fibrosis. He will continue that work at McMaster, and he will now apply his skills to identifying the bacteria that trigger episodes of Crohn's disease and ulcerative colitis". The Farncombe Institute consists of over 75 researchers exploring various aspects of the impact of digestive health of a range of diseases. In recent years the Institute has invested heavily in state-of-the-art infrastructure to support identification of the millions of species of bacteria within the human intestine.

Surette joins the Farncombe Institute on October 1st, having spent the past 12 years at the University of Calgary. 

According to Professor Gerry Wright, Director of the DeGroote Institute of Infectious Disease, "Mike Surette is arguably the most creative microbiologist in Canada today. His research program truly spans bench to bedside and his work has direct and tangible benefits to patients. He is a uniting force that will link the gastroenterology, respirology, infectious disease and chemical biology groups at McMaster and its affiliated hospitals."

Contact Information